George Vlachogiannis: Modified Glasgow Prognostic Score can reliably predict osteoporosis risk in elderly cancer patients
George Vlachogiannis, Managing Editor of Cancer Control at Sage, shared an article by Muge Ustuner, et al. on LinkedIn:
“New research published in Cancer Control demonstrates that the Modified Glasgow Prognostic Score (mGPS)—a simple, cost-effective inflammation-nutrition biomarker—can reliably predict osteoporosis risk in elderly cancer patients.
This first-of-its-kind study in Turkey highlights how higher mGPS scores are significantly associated with lower bone mineral density, especially in the lumbar spine and femur.
By integrating mGPS into routine cancer care, clinicians could proactively identify patients at risk and implement early interventions to prevent fractures and improve long-term outcomes.”
Predicting Osteoporosis in Elderly Cancer Patients Using the Modified Glasgow Prognostic Index.
Journal: Cancer Control
Authors: Muge Ustuner, et al.
More posts featuring George Vlachogiannis.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023